Compugen reported $138.36M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Arca Biopharma USD 1.23B 91.63M Sep/2026
aTyr Pharma USD 59.81M 10.02M Sep/2026
Bio Path USD 677K 13K Mar/2026
Brainstorm Cell Therapeutics USD 788K 33K Jun/2026
Cara Therapeutics USD 23.53M 2.28M Sep/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 138.36M 7.5M Jun/2026
Immunic USD 136.42M 22.75M Sep/2026
Minerva Neurosciences USD 97.97M 69.88M Dec/2025
RedHill Biopharma USD 26.27M 929K Jun/2026
TherapeuticsMD USD 40.13M 1.96M Jun/2024